CERO- Cero Therapeutics Holdings, Inc.
Classified under Biotechnology (Health Care sector), CERO's insider flows are most useful compared with peers in the same group.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.53M | $49.8K | - | |
| Other | 1.61M | $17.7K | - | |
| Dir | 1.61M | $17.7K | - | |
| CFO | 1.16M | $12.8K | - | |
| Dir | 690.9K | $7.6K | - |
Activity
Buys and sells only
Transactions
4 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | Yk Bioventures Opportunities GP I, LLC | 10% Owner | Sell | 5,957,250 | $0.07 | $400,456.43 | -11.3% | |
| Dec 10, 2024 | Yk Bioventures Opportunities GP I, LLC | 10% Owner | Sell | 3,658,364 | $0.10 | $383,369.84 | -5.7% | |
| Oct 10, 2024 | Yk Bioventures Opportunities GP I, LLC | 10% Owner | Sell | 3,250,000 | $0.10 | $325,000.00 | -12.6% | |
| Sep 25, 2024 | Sloan Stuart M | 10% Owner | Sell | 532,486 | $0.10 | $55,538.29 | -2.5% |